P451 cost effectiveness of Rifaximin-a in the reduction of recurrence of overt hepatic encephalopathy

Poole, Christopher David, Conway, P., Nanuwa, K., Joseph, B., Bannister, Christian ORCID: https://orcid.org/0000-0001-8558-9480 and Currie, Craig John 2014. P451 cost effectiveness of Rifaximin-a in the reduction of recurrence of overt hepatic encephalopathy. Journal of Hepatology 60 (1) , S219. 10.1016/S0168-8278(14)60613-9

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Computer Science & Informatics Schools > Medicine Research Institutes & Centres > MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Subjects:	R Medicine > R Medicine (General)
ISSN:	0168-8278
Last Modified:	27 Oct 2022 08:26
URI:	https://orca.cardiff.ac.uk/id/eprint/62290

Actions (repository staff only)

Edit Item